JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
GlobeNewswire
*Ad hoc announcement pursuant to Art. 53 LR*
· Idorsia receives a positive opinion from the Committee for Medicinal..
*Ad hoc announcement pursuant to Art. 53 LR*
· Idorsia receives a positive opinion from the Committee for Medicinal..
Press Release
*Atos reports first quarter 2024 performance*^*1*
*Q1 2024 Revenue €2,479m, down -2.6%..
SACRAMENTO, Calif., April 21, 2024 (GLOBE NEWSWIRE) -- AX, a pioneering AI technology company headquartered in Los Angeles, is..